ARQT Arcutis Biotherapeutics, Inc. - Common stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 5, 2026
$25,16
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$19,30rendah 52m
$31,77tinggi 52m
Kapitalisasi Pasar (MRQ)
$3.16B
P/E (TTM)
114.4
EPS (TTM)
$0.22
Pendapatan (TTM)
$464M
lencana Anda
Rentang 52M
$19–$32
Peringkat Analis
BUY
Target Harga
$37
P/E
114.4
ROE
15.9%
Margin Laba Bersih
6.1%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
ARQT Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$25.16
Kapitalisasi Pasar (MRQ)
$3.16B
P/E (TTM)
114.4
EPS (TTM)
$0.22
Pendapatan (TTM)
$464M
ROE (TTM)
15.9%
D/E Utang/Ekuitas (MRQ)
0.5
Rentang 52M
$19–$32
ARQT Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$376M2020-12-31 → 2025-12-31
EPS$-0.132019-12-31 → 2025-12-31
Arus Kas Bebas$-6M2020-12-31 → 2025-12-31
Margin bersih6.1%2023-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | ARQT | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | 114.4rata-rata 5T ≈-48.8 | ≈-48.8 | 27.9 | Terlalu mahal | |
| P/S (TTM) | 6.8rata-rata 5T ≈7.7 | ≈7.7 | 11.9 | Kurang nilai | |
| P/B (MRQ) | 14.3rata-rata 5T ≈10.9 | ≈10.9 | 4.9 | Terlalu mahal | |
| EV / EBITDA | -259.2rata-rata 5T ≈-104.4 | ≈-104.4 | · | · | |
| Harga / FCF (TTM) | 80.7rata-rata 5T ≈-194.5 | ≈-194.5 | · | · | |
| Harga / Arus Kas (TTM) | 80.4rata-rata 5T ≈-217.5 | ≈-217.5 | · | · | |
| EV / Revenue (EV / Pendapatan) | 8.4rata-rata 5T ≈8.5 | ≈8.5 | · | · | |
| EV / FCF | -502.2rata-rata 5T ≈-198.2 | ≈-198.2 | · | · | |
| Harga / Nilai Buku Berwujud (MRQ) | 15.3rata-rata 5T ≈8.7 | ≈8.7 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | ARQT | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | 7.4%rata-rata 5T ≈-157.7% | ≈-157.7% | 12.5% | Sejajar | |
| EBITDA Margin (Margin EBITDA) | -3.2%rata-rata 5T ≈-157.7% | ≈-157.7% | 12.5% | Sejajar | |
| Margin Laba Bersih (TTM) | 6.1%rata-rata 5T ≈-171.8% | ≈-171.8% | 10.2% | Sejajar | |
| ROA (TTM) | 6.8%rata-rata 5T ≈-37.0% | ≈-37.0% | -13.8% | Tingkat teratas | |
| ROE (TTM) | 15.9%rata-rata 5T ≈-162.1% | ≈-162.1% | -10.7% | Sejajar |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | ARQT | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 0.5rata-rata 5T ≈1.2 | ≈1.2 | · | · | |
| Rasio Lancar (MRQ) | 2.9rata-rata 5T ≈4.8 | ≈4.8 | 4.6 | Likuiditas rendah | |
| Quick Ratio (Rasio Cepat) | 1.5rata-rata 5T ≈1.9 | ≈1.9 | 4.1 | Likuiditas rendah | |
| Utang Jangka Panjang / Ekuitas (MRQ) | 0.5rata-rata 5T ≈1.2 | ≈1.2 | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | ARQT | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 91.3%rata-rata 5T ≈612.7% | ≈612.7% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 367.3% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | ARQT | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 1.0rata-rata 5T ≈0.6 | ≈0.6 | 0.4 | Tingkat teratas | |
| Inventory Turnover (Perputaran Persediaan) | 2.0rata-rata 5T ≈1.3 | ≈1.3 | · | · | |
| Receivables Turnover (Perputaran Piutang) | 3.4rata-rata 5T ≈3.6 | ≈3.6 | 8.4 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$1.1M | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
56.7%
Laporan Berikutnya
Okt 26, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 4, 2026 | $0.11 | $0.04 | 150.6% |
| 31 Maret 2026 | $-0.09 | $-0.08 | -7.4% | |
| 31 Des. 2025 | $0.13 | $0.12 | 12.4% | |
| 30 Sep. 2025 | $0.06 | $-0.10 | 158.9% | |
| 30 Juni 2025 | $-0.13 | $-0.16 | 19.4% | |
| 31 Maret 2025 | $-0.20 | $-0.21 | 6.6% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $376M | $197M | $60M | $4M | $0 | $0 | |
| Cost of Revenue | $37M | $19M | $5M | $754.0K | $0 | · | |
| R&D Expense | $77M | $76M | $111M | $182M | $146M | $115M | |
| SG&A Expense | $275M | $229M | $185M | $122M | $61M | $21M | |
| Operating Expenses | $388M | $325M | $301M | $305M | $207M | $137M | |
| Operating Income | $-12M | $-128M | $-241M | $-302M | $-207M | $-137M | |
| Interest Expense | · | · | $30M | $16M | $0 | $0 | |
| Other Non-op | $443.0K | $47.0K | $-731.0K | $6M | $173.0K | $967.0K | |
| Income Tax | $1M | $647.0K | $3M | $0 | $0 | $0 | |
| Net Income | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| EPS (Basic) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| EPS (Diluted) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 | |
| Shares (Basic) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| Shares (Diluted) | 127,234,000 | 120,958,000 | 69,305,000 | 55,032,265 | 49,405,575 | 35,668,152 | |
| EBITDA | $-12M | $-128M | $-241M | · | · | $-137M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $43M | $71M | $88M | $54M | $96M | $65M | |
| Receivables | $146M | $73M | $26M | $8M | $0 | · | |
| Inventory | $23M | $15M | $13M | $8M | $0 | · | |
| Prepaid Expense | $21M | $20M | $19M | $11M | $14M | $7M | |
| Current Assets | $411M | $336M | $330M | $437M | $403M | $293M | |
| PP&E (Net) | $1M | $1M | $2M | $2M | $2M | $2M | |
| PP&E (Gross) | $4M | $4M | $3M | $3M | $3M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $1M | $532.0K | $78.0K | |
| Intangibles | $15M | $9M | $6M | $7M | $0 | · | |
| Other Non-current Assets | $1M | $596.0K | $596.0K | $78.0K | $78.0K | $78.0K | |
| Total Assets | $433M | $349M | $341M | $449M | $408M | $298M | |
| Accounts Payable | $13M | $14M | $12M | $9M | $7M | $7M | |
| Accrued Liabilities | $116M | $67M | $34M | $28M | $26M | $15M | |
| Current Liabilities | $130M | $81M | $47M | $38M | $33M | $23M | |
| Capital Leases | $5M | $3M | $3M | $4M | $5M | $5M | |
| Other Non-current Liabilities | $431.0K | $570.0K | $849.0K | $0 | $25.0K | $82.0K | |
| Total Liabilities | $243M | $191M | $253M | $240M | $110M | $28M | |
| Long-term Debt | $109M | $107M | $202M | $198M | $72M | $0 | |
| Total Debt | $109M | $107M | $202M | · | · | · | |
| Common Stock | $12.0K | $12.0K | $9.0K | $6.0K | $5.0K | $4.0K | |
| Paid-in Capital | $1.33B | $1.28B | $1.07B | $930M | $706M | $473M | |
| Retained Earnings | $-1.14B | $-1.12B | $-982M | $-720M | $-408M | $-202M | |
| AOCI | $-44.0K | $-7.0K | $4.0K | $-1M | $-255.0K | $-2.0K | |
| Stockholders' Equity | $189M | $158M | $89M | $210M | $298M | $271M | |
| Liabilities + Equity | $433M | $349M | $341M | $449M | $408M | $298M | |
| Shares Outstanding | 123,333,000 | 117,848,033 | 96,787,343 | 61,037,403 | 50,255,614 | 43,338,438 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $40M | $42M | $39M | $33M | $24M | $8M | |
| Deferred Tax | $54.0K | $-152.0K | $0 | $0 | $0 | · | |
| Amort. of Intangibles | $5M | $2M | $750.0K | $312.0K | $0 | $0 | |
| Operating Cash Flow | $-6M | $-112M | $-247M | $-258M | $-175M | $-113M | |
| CapEx | $686.0K | $143.0K | $428.0K | $333.0K | $995.0K | $321.0K | |
| Investing Cash Flow | $-30M | $29M | $180M | $-87M | $-76M | $-182M | |
| Debt Issued | · | $0 | $0 | $125M | $74M | $0 | |
| Net Debt Issued | $0 | $-100M | $0 | · | · | · | |
| Stock Issued | $0 | $162M | $0 | $162M | $207M | $128M | |
| Net Stock Activity | $0 | $162M | $0 | · | · | $128M | |
| Financing Cash Flow | $7M | $66M | $101M | $302M | $282M | $298M | |
| Net Change in Cash | $-29M | $-17M | $34M | $-43M | $31M | $3M | |
| Taxes Paid | $0 | $0 | $0 | · | · | · | |
| Free Cash Flow | $-6M | $-112M | $-247M | · | · | $-113M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| Net Margin | -4.3% | -71.2% | -439.8% | · | · | · | |
| EBITDA Margin | -3.2% | -65.3% | -404.5% | · | · | · | |
| ROA | -4.1% | -40.6% | -66.3% | · | · | -67.0% | |
| ROE | -9.8% | -89.1% | -387.2% | · | · | -61.2% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.2 | 4.1 | 7.1 | · | · | 13.0 | |
| Quick Ratio | 1.5 | 1.8 | 2.4 | · | · | 2.9 | |
| Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| LT Debt / Equity | 0.6 | 0.7 | 2.3 | · | · | · | |
| Interest Coverage | · | · | -8.1 | · | · | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.6 | 0.2 | · | · | · | |
| Inventory Turnover | 2.0 | 1.4 | 0.5 | · | · | · | |
| Receivables Turnover | 3.4 | 4.0 | 3.5 | · | · | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.54 | $1.34 | $0.92 | · | · | $6.24 | |
| Revenue / Share | $2.96 | $1.62 | $0.86 | · | · | · | |
| Cash Flow / Share | $-0.04 | $-0.93 | $-3.56 | · | · | · | |
| Cash / Share | $0.35 | $0.61 | $0.91 | · | · | $1.50 | |
| EPS (TTM) | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 | $-3.80 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 91.3% | 229.7% | 1517.1% | · | · | · | |
| Revenue CAGR 3Y | 367.3% | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $376M | $197M | $60M | $4M | $0 | $0 | |
| Net Income TTM | $-16M | $-140M | $-262M | $-311M | $-206M | $-136M | |
| Market Cap | $3.58B | $1.64B | $313M | · | · | $1.22B | |
| Enterprise Value | $3.65B | $1.68B | $426M | · | · | · | |
| P/E | -223.4 | -12.0 | -0.9 | -2.6 | -5.0 | -7.4 | |
| P/S | 9.5 | 8.4 | 5.2 | · | · | · | |
| P/B | 18.9 | 10.4 | 3.5 | · | · | 4.5 | |
| P / Tangible Book | 20.5 | 11.1 | 3.8 | 4.5 | 3.5 | 4.5 | |
| P / Cash Flow | -636.7 | -14.6 | -1.3 | · | · | -10.8 | |
| P / FCF | -567.5 | -14.6 | -1.3 | · | · | -10.8 | |
| EV / EBITDA | -298.3 | -13.1 | -1.8 | · | · | · | |
| EV / FCF | -578.0 | -14.9 | -1.7 | · | · | · | |
| EV / Revenue | 9.7 | 8.5 | 7.1 | · | · | · | |
| Earnings Yield | -0.45% | -8.3% | -117.0% | -38.2% | -20.2% | -13.5% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $130M | $105M | $130M | $99M | $82M | $66M | $71M | $45M | $31M | $50M | $14M | $38M | $5M | $3M | $3M | $725.0K | |
| Cost of Revenue | $11M | $10M | $12M | $9M | $7M | $9M | $7M | $6M | $3M | $3M | $2M | $1M | $776.0K | $783.0K | · | · | |
| R&D Expense | $20M | $31M | $20M | $20M | $19M | $18M | $14M | $20M | $19M | $23M | $24M | $26M | $25M | $35M | $34M | $70M | |
| SG&A Expense | $82M | $74M | $79M | $62M | $69M | $64M | $58M | $59M | $58M | $55M | $49M | $48M | $46M | $43M | $37M | $35M | |
| Operating Expenses | $113M | $114M | $111M | $91M | $96M | $90M | $79M | $84M | $81M | $81M | $75M | $75M | $72M | $79M | $71M | $105M | |
| Operating Income | $16M | $-9M | $18M | $9M | $-15M | $-25M | $-8M | $-39M | $-50M | $-32M | $-61M | $-37M | $-67M | $-76M | $-68M | $-105M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $7M | · | $8M | $7M | $7M | · | $5M | |
| Interest Income | $2M | · | · | · | $2M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-157.0K | $-20.0K | $-6M | $2M | $20.0K | $193.0K | $-13M | $4M | $5M | $4M | $-10M | $3M | $3M | $3M | $3M | $2M | |
| Income Tax | $136.0K | $93.0K | $470.0K | $80.0K | $342.0K | $279.0K | $323.0K | $0 | $0 | $324.0K | $90.0K | $3M | $0 | $0 | $0 | $0 | |
| Net Income | $15M | $-11M | $17M | $7M | $-16M | $-25M | $-11M | $-42M | $-52M | $-35M | $-66M | $-45M | $-71M | $-80M | $-72M | $-108M | |
| EPS (Basic) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| EPS (Diluted) | $0.11 | $-0.09 | $0.14 | $0.06 | $-0.13 | $-0.20 | $-0.09 | $-0.33 | $-0.42 | $-0.32 | $-0.58 | $-0.73 | $-1.16 | $-1.31 | $-1.19 | $-1.89 | |
| Shares (Basic) | 130,522,000 | 129,365 | · | 127,623,000 | 126,997,000 | 126,037 | · | 124,302,000 | 123,481,000 | 111,048,525 | · | 61,727,278 | 61,430,620 | 61,169,089 | · | 57,091,743 | |
| Shares (Diluted) | 135,898,000 | 129,365 | · | 132,885,000 | 126,997,000 | 126,037 | · | 124,302,000 | 123,481,000 | 111,048,525 | · | 61,727,278 | 61,430,620 | 61,169,089 | · | 57,091,743 | |
| EBITDA | $16M | $-9M | · | $9M | $-15M | $-25M | · | $-39M | $-50M | · | · | $-37M | · | · | · | $-105M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $34M | $35M | $43M | $47M | $73M | $53M | $71M | $135M | $84M | $190M | · | $107M | $105M | $81M | · | $82M | |
| Receivables | $155M | $144M | $146M | $115M | $107M | $85M | $73M | $60M | $43M | $37M | · | $19M | $17M | $13M | · | $2M | |
| Inventory | $39M | $37M | $23M | $22M | $16M | $17M | $15M | $14M | $14M | $13M | · | $14M | $10M | $9M | · | $4M | |
| Prepaid Expense | $35M | $32M | $21M | $20M | $19M | $23M | $20M | $18M | $14M | $13M | · | $20M | $12M | $13M | · | $12M | |
| Current Assets | $468M | $438M | $411M | $349M | $333M | $324M | $336M | $424M | $435M | $468M | · | $282M | $309M | $368M | · | $497M | |
| PP&E (Net) | $872.0K | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| PP&E (Gross) | · | · | $4M | · | · | · | $4M | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Accum. Depreciation | · | · | $3M | · | · | · | $3M | · | · | · | · | $2M | $2M | $1M | · | $993.0K | |
| Intangibles | $14M | $14M | $15M | $15M | $16M | $16M | $9M | $10M | $6M | $6M | · | $7M | $7M | $7M | · | $7M | |
| Other Non-current Assets | $2M | $2M | $1M | $596.0K | $596.0K | $596.0K | $596.0K | $596.0K | $595.0K | $596.0K | · | $596.0K | $596.0K | $78.0K | · | $78.0K | |
| Total Assets | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Accounts Payable | $7M | $18M | $13M | $6M | $15M | $25M | $14M | $19M | $8M | $13M | · | $13M | $17M | $12M | · | $9M | |
| Accrued Liabilities | $147M | $137M | $116M | $93M | $88M | $66M | $67M | $53M | $43M | $34M | · | $28M | $19M | $24M | · | $28M | |
| Current Liabilities | $160M | $163M | $130M | $100M | $104M | $91M | $81M | $172M | $51M | $47M | · | $42M | $37M | $37M | · | $37M | |
| Capital Leases | $5M | $5M | $5M | $5M | $2M | $2M | $3M | $3M | $3M | $3M | · | $4M | $4M | $4M | · | $4M | |
| Other Non-current Liabilities | $431.0K | $431.0K | $431.0K | $360.0K | $360.0K | $360.0K | $570.0K | $420.0K | $194.0K | $306.0K | · | · | · | · | · | $0 | |
| Total Liabilities | $268M | $270M | $243M | $213M | $213M | $201M | $191M | $281M | $258M | $254M | · | $246M | $240M | $240M | · | $238M | |
| Long-term Debt | $109M | $109M | $109M | $108M | $108M | $108M | $107M | $205M | $204M | $203M | · | $201M | $200M | $199M | · | $197M | |
| Total Debt | $109M | $109M | · | $108M | $108M | $108M | · | $205M | $204M | · | · | $201M | · | · | · | $197M | |
| Common Stock | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | $12.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Paid-in Capital | $1.36B | $1.34B | $1.33B | $1.31B | $1.30B | $1.29B | $1.28B | $1.27B | $1.26B | $1.24B | · | $963M | $952M | $940M | · | $920M | |
| Retained Earnings | $-1.13B | $-1.15B | $-1.14B | $-1.16B | $-1.16B | $-1.15B | $-1.12B | $-1.11B | $-1.07B | $-1.02B | · | $-916M | $-871M | $-800M | · | $-648M | |
| AOCI | $-656.0K | $-514.0K | $-44.0K | $-62.0K | $-35.0K | $-140.0K | $-7.0K | $533.0K | $-294.0K | $-133.0K | · | $-184.0K | $-292.0K | $-414.0K | · | $-2M | |
| Stockholders' Equity | $221M | $190M | $189M | $158M | $139M | $143M | $158M | $157M | $186M | $225M | $89M | $47M | $81M | $140M | $210M | $271M | |
| Liabilities + Equity | $489M | $460M | $433M | $371M | $352M | $344M | $349M | $437M | $445M | $479M | · | $293M | $321M | $379M | · | $509M | |
| Shares Outstanding | 125,591,000 | 125,042,000 | 123,332,672 | 120,288,146 | 119,797,738 | 119,137,785 | 117,848,033 | 116,998,829 | 116,480,267 | 115,505,437 | · | 61,858,044 | 61,630,018 | 61,357,932 | · | 60,908,641 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $13M | $11M | $10M | $10M | $10M | $10M | $9M | $10M | $13M | $10M | $9M | $10M | $11M | $9M | $9M | $9M | |
| Amort. of Intangibles | $563.0K | $562.0K | $563.0K | $562.0K | $563.0K | $3M | $313.0K | $1M | $200.0K | $188.0K | $-188M | $188M | $200.0K | $188.0K | $187.0K | $125.0K | |
| Operating Cash Flow | $13M | $2M | $26M | $-2M | $324.0K | $-30M | $-748.0K | $-35M | $-45M | $-32M | $-56M | $-44M | $-66M | $-80M | $-71M | $-68M | |
| CapEx | $158.0K | $0 | $0 | $0 | $78.0K | $608.0K | $0 | $143.0K | $0 | $0 | $6.0K | $64.0K | $276.0K | $82.0K | $123.0K | $6.0K | |
| Investing Cash Flow | $-15M | $-11M | $-34M | $-25M | $17M | $12M | $35M | $85M | $-62M | $-29M | $-62M | $46M | $89M | $108M | $42M | $-197M | |
| Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | |
| Stock Issued | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $162M | $0 | $0 | $0 | $0 | $0 | $162M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $2M | $1M | $4M | $1M | $1M | $395.0K | $-97M | $394.0K | $1M | $162M | $99M | $867.0K | $1M | $100.0K | $962.0K | $285M | |
| Net Change in Cash | $-641.0K | $-8M | $-4M | $-26M | $19M | $-18M | $-64M | $51M | $-106M | $101M | $-19M | $2M | $24M | $27M | $-28M | $20M | |
| Free Cash Flow | · | $2M | · | · | · | $-31M | · | · | · | · | · | · | · | · | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| Net Margin | 11.6% | -10.7% | · | 7.5% | -19.5% | -38.1% | · | -92.8% | -169.6% | · | · | -117.5% | · | · | · | -14856.4% | |
| EBITDA Margin | 12.7% | -8.6% | · | 8.6% | -17.9% | -37.2% | · | -87.3% | -162.3% | · | · | -96.8% | · | · | · | -14448.0% | |
| ROA | 3.6% | -2.8% | · | 1.8% | -4.0% | -6.1% | · | -11.4% | -13.7% | · | · | -11.2% | · | · | · | -24.0% | |
| ROE | 8.3% | -6.8% | · | 4.7% | -9.8% | -13.6% | · | -40.8% | -39.2% | · | · | -28.2% | · | · | · | -34.0% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.7 | · | 3.5 | 3.2 | 3.6 | · | 2.5 | 8.5 | · | · | 6.7 | · | · | · | 13.4 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.6 | 1.7 | 1.5 | · | 1.1 | 2.5 | · | · | 3.0 | · | · | · | 2.3 | |
| Debt / Equity | 0.5 | 0.6 | · | 0.7 | 0.8 | 0.8 | · | 1.3 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| LT Debt / Equity | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.8 | · | 0.7 | 1.1 | · | · | 4.3 | · | · | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -4.9 | · | · | · | -21.4 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | · | · | 0.1 | · | · | · | 0.0 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.6 | · | 0.4 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.0 | 0.9 | · | 1.1 | 1.1 | 1.1 | · | 1.1 | 1.0 | · | · | 3.5 | · | · | · | 0.6 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.76 | $1.52 | · | $1.31 | $1.16 | $1.20 | · | $1.34 | $1.60 | · | · | $0.76 | · | · | · | $4.45 | |
| Revenue / Share | $0.96 | $814.73 | · | $0.75 | $0.64 | $0.52 | · | $0.36 | $0.25 | · | · | $0.62 | · | · | · | $0.01 | |
| Cash Flow / Share | · | $17.31 | · | · | · | $-0.24 | · | · | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.27 | $0.28 | · | $0.39 | $0.61 | $0.45 | · | $1.15 | $0.72 | · | · | $1.74 | · | · | · | $1.34 | |
| EPS (TTM) | $0.22 | $-0.02 | · | $-0.36 | $-0.75 | $-1.04 | · | $-1.65 | $-2.05 | $-3.52 | · | $-4.39 | $-5.67 | $-5.78 | · | $-5.91 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $464M | $416M | · | $318M | $263M | $213M | · | $139M | $132M | $96M | · | $49M | $9M | $4M | · | $725.0K | |
| Net Income TTM | $29M | $-2M | · | $-44M | $-93M | $-130M | · | $-196M | $-199M | $-231M | · | $-268M | $-326M | $-320M | · | $-311M | |
| Market Cap | $3.29B | $2.95B | · | $2.27B | $1.68B | $1.86B | · | $1.09B | $1.08B | · | · | $328M | · | · | · | $1.16B | |
| Enterprise Value | $3.37B | $3.02B | · | $2.33B | $1.71B | $1.92B | · | $1.16B | $1.20B | · | · | $422M | · | · | · | $1.28B | |
| P/E | 119.2 | -1178.0 | · | -52.4 | -18.7 | -15.0 | · | -5.6 | -4.5 | -2.8 | · | -1.2 | -1.7 | -1.9 | · | -3.2 | |
| P/S | 7.1 | 7.1 | · | 7.1 | 6.4 | 8.8 | · | 7.8 | 8.2 | · | · | 6.7 | · | · | · | 1605.5 | |
| P/B | 14.9 | 15.5 | · | 14.3 | 12.1 | 13.1 | · | 6.9 | 5.8 | · | · | 7.0 | · | · | · | 4.3 | |
| P / Tangible Book | 15.9 | 16.8 | · | 15.9 | 13.7 | 14.8 | · | 7.4 | 6.0 | 5.2 | · | 8.2 | 8.0 | 5.1 | · | 4.4 | |
| P / Cash Flow | · | 1315.8 | · | · | · | -61.3 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 7.3 | 7.3 | · | 7.3 | 6.5 | 9.0 | · | 8.3 | 9.1 | · | · | 8.6 | · | · | · | 1764.4 | |
| Earnings Yield | 0.84% | -0.08% | · | -1.9% | -5.3% | -6.7% | · | -17.7% | -22.0% | -35.5% | · | -82.7% | -59.5% | -52.5% | · | -30.9% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $376M | $197M | $60M | $4M | $0 |
| Margin Operasi % | -3.2% | -65.3% | -404.5% | · | · |
| Laba Bersih | $-16M | $-140M | $-262M | $-311M | $-206M |
| EPS Dilusian | $-0.13 | $-1.16 | $-3.78 | $-5.66 | $-4.18 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.6 | 0.7 | 2.3 | · | · |
| Rasio Lancar | 3.2 | 4.1 | 7.1 | · | · |
| Rasio Cepat | 1.5 | 1.8 | 2.4 | · | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-6M | $-112M | $-247M | · | · |
Pemilik institusional (13F) 289 pengaju · $3.6B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
289
Nilai yang dipegang
$3.6B
Posisi baru
39
Posisi yang keluar
33
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 39 (-4 vs Kuartal sebelumnya) | 33 (-9 vs Kuartal sebelumnya) | 93 (-10 vs Kuartal sebelumnya) | 101 (+13 vs Kuartal sebelumnya) | -1.9M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | $326.098.140 | 12.437.000 | 8,97% | Saham |
| BlackRock, Inc. | $276.502.120 | 10.545.466 | 7,61% | Saham |
| Frazier Life Sciences Management, L.P. | $258.909.678 | 9.874.511 | 7,12% | Saham |
| Rubric Capital Management LP | $216.880.749 | 8.271.577 | 5,97% | Saham |
| VANGUARD GROUP INC | $210.654.301 | 7.253.936 | 5,80% | Saham |
| Polar Capital Holdings Plc | $173.234.098 | 6.606.945 | 4,77% | Saham |
| STATE STREET CORP | $152.674.865 | 5.822.840 | 4,20% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $130.805.182 | 4.988.756 | 3,60% | Saham |
| MORGAN STANLEY | $116.705.607 | 4.451.014 | 3,21% | Saham |
| JENNISON ASSOCIATES LLC | $110.623.703 | 4.219.058 | 3,04% | Saham |
| D. E. Shaw & Co., Inc. | $103.558.748 | 3.949.609 | 2,85% | Saham |
| UBS Group AG | $87.391.654 | 3.333.015 | 2,40% | Saham |
| BANK OF AMERICA CORP /DE/ | $78.330.441 | 2.987.431 | 2,16% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $78.214.092 | 2.982.446 | 2,15% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $63.688.511 | 2.429.005 | 1,75% | Saham |
| ORBIMED ADVISORS LLC | $53.541.240 | 2.042.000 | 1,47% | Saham |
| FRANKLIN RESOURCES INC | $50.630.354 | 1.930.982 | 1,39% | Saham |
| AMERICAN CENTURY COMPANIES INC | $50.474.363 | 1.925.031 | 1,39% | Saham |
| GOLDMAN SACHS GROUP INC | $43.744.582 | 1.668.367 | 1,20% | Saham |
| JANUS HENDERSON GROUP PLC | $43.684.303 | 1.854.566 | 1,20% | Saham |
| OBERWEIS ASSET MANAGEMENT INC/ | $35.998.513 | 1.372.941 | 0,99% | Saham |
| GILDER GAGNON HOWE & CO LLC | $34.432.392 | 1.313.211 | 0,95% | Saham |
| Pivotal bioVenture Partners Investment Advisor LLC | $33.175.720 | 1.265.283 | 0,91% | Saham |
| BAMCO INC /NY/ | $32.856.806 | 1.253.120 | 0,90% | Saham |
| CITADEL ADVISORS LLC | $30.415.567 | 1.160.014 | 0,84% | Saham |
| FEDERATED HERMES, INC. | $29.487.772 | 1.124.629 | 0,81% | Saham |
| Perpetual Ltd | $29.095.206 | 1.109.657 | 0,80% | Saham |
| Aberdeen Group plc | $28.800.336 | 1.098.411 | 0,79% | Saham |
| Jones Hill Capital LP | $28.571.960 | 1.089.701 | 0,79% | Saham |
| NORTHERN TRUST CORP | $27.755.837 | 1.058.575 | 0,76% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $27.555.489 | 1.050.934 | 0,76% | Saham |
| Ensign Peak Advisors, Inc | $25.552.281 | 974.534 | 0,70% | Saham |
| Candriam S.C.A. | $24.880.817 | 949.839 | 0,68% | Saham |
| Driehaus Capital Management LLC | $23.032.330 | 878.426 | 0,63% | Saham |
| Nuveen, LLC | $21.874.324 | 834.261 | 0,60% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $21.372.918 | 815.138 | 0,59% | Saham |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $21.284.137 | 811.752 | 0,59% | Saham |
| TWO SIGMA INVESTMENTS, LP | $17.406.855 | 663.877 | 0,48% | Saham |
| FISHMAN JAY A LTD/MI | $15.601.031 | 595.005 | 0,43% | Saham |
| MILLENNIUM MANAGEMENT LLC | $14.789.968 | 564.072 | 0,41% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $14.349.629 | 547.278 | 0,39% | Saham |
| Squarepoint Ops LLC | $14.099.726 | 537.747 | 0,39% | Saham |
| CAPITOLIS LIQUID GLOBAL MARKETS LLC | $13.110.000 | 500.000 | 0,36% | Saham |
| Nearwater Capital Markets, Ltd | $12.761.274 | 486.700 | 0,35% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $12.218.520 | 466.000 | 0,34% | Saham |
| MARSHALL WACE, LLP | $11.716.827 | 446.866 | 0,32% | Saham |
| Privium Fund Management B.V. | $10.471.403 | 399.367 | 0,29% | Saham |
| NORGES BANK | $10.286.106 | 392.300 | 0,28% | Saham |
| DEUTSCHE BANK AG\ | $10.033.923 | 382.682 | 0,28% | Saham |
| Patient Square Capital LP | $9.701.400 | 370.000 | 0,27% | Saham |
Aktivis & pemilik 5%+ 3 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P., FHM LIFE SCIENCES VIII, L.P., FHM LIFE SCIENCES VIII, L.L.C., Frazier Life Sciences X, L.P., FHMLS X, L.P., FHMLS X, L.L.C., Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C., Frazier Life Sciences Public Overage Fund, L.P., FHMLSP Overage, L.P., FHMLSP Overage, L.L.C., Frazier Life Sciences XI, L.P., FHMLS XI, L.P., FHMLS XI, L.L.C., Frazier Life Sciences XII, L.P., FHMLS XII, L.P., FHMLS XII, L.L.C., James N. Topper, Patrick J. Heron ×8 pengajuan | 20 Agu 2025 | 7,50% | Amandemen | Investasi pasif | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Capital LLC ×7 pengajuan | 26 Agu 2022 | · | Pengajuan awal | · | SEC |
| Bain Capital Life Sciences Fund, L.P., BCIP Life Sciences Associates, LP ×4 pengajuan | 8 Agu 2022 | · | Pengajuan awal | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 26 orang dalam · 12 pejabat · 14 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Todd Franklin Watanabe | Reporting Person's title: President and Chief Executive Officer | 3 Agu 2026 S | 717.203 | 0 | 10 | $-4.439.604 |
| Latha Vairavan | SVP Chief Financial Officer | 11 Mei 2026 S | 85.978 | 0 | 6 | $-148.496 |
| David Joseph Topper | Chief Financial Officer | 2 April 2025 S | 182.774 | 0 | 0 | $0 |
| John W Smither | Chief Financial Officer | 13 Feb. 2024 D | 11.365 | 0 | 0 | $0 |
| Scott L Burrows | Chief Financial Officer | 6 Maret 2023 S | 59.115 | 0 | 0 | $0 |
| Masaru Matsuda | Reporting Person's title: EVP, Chief Legal Officer | 16 Sep. 2026 S | 112.508 | 0 | 18 | $-2.207.960 |
| Patrick Burnett | Reporting Person's title: EVP, Chief Medical Officer | 19 Agu 2026 S | 117.592 | 0 | 18 | $-2.019.340 |
| Larry Todd Edwards | Reporting Person's title: EVP, Chief Commercial Officer | 27 Feb. 2026 A | 175.178 | 0 | 6 | $-968.374 |
| Matthew Richard Moore | SVP and Chief Business Officer | 2 Mei 2024 S | 145.505 | 0 | 0 | $0 |
| Kenneth A. Lock | Chief Commercial Officer | 6 Maret 2023 S | 63.429 | 0 | 0 | $0 |
| Patricia A. Turney | SVP, Operations | 6 Maret 2023 S | 62.862 | 0 | 0 | $0 |
| David W Osborne | Chief Technical Officer | 6 Maret 2023 S | 268.854 | 0 | 0 | $0 |
| Howard G. Welgus | Direktur | 15 Sep. 2026 M | 35.841 | 0 | 12 | $-2.236.210 |
| Terrie Curran | Direktur | 27 Agu 2026 M | 23.526 | 0 | 3 | $-984.061 |
| Christopher Peetz | Direktur | 15 Juli 2026 A | 4.315 | 0 | 0 | $0 |
| Sue-Jean Lin | Direktur | 15 Juni 2026 S | 27.567 | 0 | 2 | $-898.455 |
| Neha Krishnamohan | Direktur | 5 Juni 2026 A | 27.901 | 0 | 2 | $-939.510 |
| Amit Munshi | Direktur | 5 Juni 2026 A | 9.799 | 0 | 0 | $0 |
| Halley E Gilbert | Direktur | 5 Juni 2026 A | 27.901 | 0 | 1 | $-455.457 |
| Keith R Leonard | Direktur | 5 Juni 2026 A | 27.901 | 0 | 1 | $-997.116 |
| Patrick J. Heron | Direktur | 5 Juni 2026 A | 32.213 | 0 | 0 | $0 |
| Bhaskar Chaudhuri | Direktur | 12 Juni 2025 A | 867.826 | 0 | 0 | $0 |
| Joseph L Turner | Direktur | 1 Juni 2022 A | 4.312 | 0 | 0 | $0 |
| Jonathan Silverstein | Direktur | 2 Okt. 2020 P | 902.286 | 0 | 0 | $0 |
| Daniel Estes | Direktur | 27 Feb. 2020 A | · | 0 | 0 | $0 |
| Ricky Sun | · | 9 Juni 2021 A | · | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 37 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| RZG · Invesco Exchange-Traded Fund Trust | 1,63% | 77.200 SH | 2 Okt. 2026 | Harian |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,58% | 108.697 SH | 2 Okt. 2026 | Harian |
| BBP · ETFis Series Trust I | 1,52% | 55.666 NS | 31 Juli 2026 | N-PORT |
| GURU · Global X Funds | 1,46% | 33.313 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,54% | 98.745 NS | 31 Juli 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,41% | 197.027 NS | 31 Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,38% | 61.480 SH | 2 Okt. 2026 | Harian |
| NUSC · Nushares ETF Trust | 0,22% | 107.502 NS | 31 Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,21% | 8.879 SH | 2 Okt. 2026 | Harian |
| IBB · iShares Trust | 0,19% | 842.985 SH | 11 Sep. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,18% | 122.691 SH | 19 Agu 2026 | Harian |
| IWO · iShares Trust | 0,18% | 1.074.467 SH | 11 Sep. 2026 | Harian |
| PWS · Pacer Funds Trust | 0,15% | 1.349 NS | 31 Juli 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,13% | 66.540 NS | 31 Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,12% | 3.883 NS | 31 Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 29.355 NS | 31 Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,10% | 54.786 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 658.480 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,09% | 2.915.298 SH | 11 Sep. 2026 | Harian |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,08% | 17.847 NS | 31 Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,08% | 34.084 SH | 11 Sep. 2026 | Harian |
| ESML · iShares Trust | 0,07% | 88.662 SH | 11 Sep. 2026 | Harian |
| VFMO · VANGUARD WELLINGTON FUND | 0,07% | 55.080 SH | 19 Agu 2026 | Harian |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,05% | 5.568 SH | 2 Okt. 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 53.372 NS | 31 Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 45.122 SH | 2 Okt. 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,04% | 335.913 SH | 19 Agu 2026 | Harian |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,03% | 24.688 SH | 2 Okt. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1.307.970 SH | 19 Agu 2026 | Harian |
| WSML · iShares Trust | 0,02% | 6.362 SH | 11 Sep. 2026 | Harian |
| TILT · FlexShares Trust | 0,00% | 3.204 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152.928 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 31.652 SH | 10 Sep. 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.565.928 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.521 SH | 19 Agu 2026 | Harian |
| PTH · Invesco Exchange-Traded Fund Trust | 0,00% | 2 SH | 2 Okt. 2026 | Harian |
| ISCB · iShares Trust | · | 4.781 SH | 11 Sep. 2026 | Harian |
ARQT Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 14 analis
BELI
Target median
$38.00
+51,0%
4 28,6%
Beli Kuat
8 57,1%
Beli
2 14,3%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
7 analis · 2026-10-01Target rata-rata $37.00 +47,1%
← Di bawah semua target
Harga saat ini $25.16
Rendah$34.00
Rata-rata$37.00
Tinggi$40.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 5, 2026